Envisioned as bioRxiv’s clinical cousin, the new preprint server medRxiv hosts unpublished manuscripts describing original medical research.

Results from a new trial suggest that it’s safe to treat autistic children with umbilical cord stem cells. But parents must pay for the pricey infusions, and no one knows how or if the cells work.

A drug that mimics the hormone vasopressin improves social skills in autistic people — but so does one that blocks vasopressin’s effects. How can seemingly opposing manipulations produce similar results?

The lack of people with intellectual disability in studies of autism has a profound effect on our understanding of the condition.

Two drugs that alter the activity of the hormone vasopressin seem to improve social communication in autistic people, but some experts question the findings.

Parents of children with rare autism-linked mutations are banding together for support and to join forces with scientists, accelerating the pace of research.

Parents of autistic children are paying tens of thousands of dollars for stem cell therapies that often use medical waste. Despite the risks, regulators have been slow to act.

A much-touted behavioral therapy for autism, the Early Start Denver Model, may not be as effective as its creators had hoped.

Autism doesn’t just affect boys and men, but research on the condition still predominantly focuses on them. Some scientists are finally beginning to include women and nonbinary people in their studies.

A popular system used to detect speech may not identify most vocalizations produced by autistic children aged 5 and older.